Pharmaceutical

AstraZeneca scores its second paediatric approval for Soliris in Japan

Soliris is already approved to treat refractory generalised myasthenia gravis in adults in different regions.

Aug 26, 2023 - 20:00
AstraZeneca scores its second paediatric approval for Soliris in Japan
Soliris is already approved to treat refractory generalised myasthenia gravis in adults in different regions.
Read the original article

Tags:

Previous Article

Microbiome company Enterome plans $108m raise to fund Phase II cancer trials

Next Article

Wegovy can reduce heart failure symptoms in obese patients, study shows

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

House Democrats unveil new legislation that expands the Inflation Reduction Act

House Democrats unveil new legislation that expands the...

Aug 14, 2023

NPX-267 by NextPoint Therapeutics for Osteosarcoma: Likelihood of Approval

NPX-267 by NextPoint Therapeutics for Osteosarcoma: Lik...

Jun 14, 2024

ASCO 2023: Research backs chemo-only approach for some rectal cancer patients

ASCO 2023: Research backs chemo-only approach for some ...

Jun 5, 2023